Last reviewed 2026-05-15 · How we verify

CK-3773274 - Granules in Capsule

Cytokinetics · Phase 1 active Small molecule

CK-3773274 - Granules in Capsule is a Small molecule drug developed by Cytokinetics. It is currently in Phase 1 development.

At a glance

Generic name	CK-3773274 - Granules in Capsule
Sponsor	Cytokinetics
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CK-3773274 - Granules in Capsule CI brief — competitive landscape report
CK-3773274 - Granules in Capsule updates RSS · CI watch RSS
Cytokinetics portfolio CI

Frequently asked questions about CK-3773274 - Granules in Capsule

What is CK-3773274 - Granules in Capsule?

CK-3773274 - Granules in Capsule is a Small molecule drug developed by Cytokinetics.

Who makes CK-3773274 - Granules in Capsule?

CK-3773274 - Granules in Capsule is developed by Cytokinetics (see full Cytokinetics pipeline at /company/cytokinetics).

What development phase is CK-3773274 - Granules in Capsule in?

CK-3773274 - Granules in Capsule is in Phase 1.

Manufacturer: Cytokinetics — full pipeline
Compare: CK-3773274 - Granules in Capsule vs similar drugs
Pricing: CK-3773274 - Granules in Capsule cost, discount & access